Rejuvel Bio-Sciences IncOver The Counter Market:NUUU
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rejuvel Bio-Sciences Inc | 50.0 | 0.0x | --- |
Oxford Investments Holdings Inc | 630.0 | --- | --- |
Tradeshow Marketing Company Ltd | 20.0 | 0.0x | --- |
Sativa Growth International | 620.0 | 0.0x | --- |
Deep Field Technologies Inc | 1.2K | 0.0x | --- |
Gentech Holdings Inc | 30.5K | 0.0x | --- |
Company Information
Rejuvel Bio-Sciences, Inc., formerly Technology Applications International Corporation, is engaged in developing market entry technology products and services into early and mainstream technology products and services. The Company, through its subsidiaries, is focused on developing and manufacturing a line of technologically advanced skin care products and providing environmental management solutions that use electron particle accelerator technology. The Company offers REJUVEL 3D, which is ageless infinity microgravity cell renewal cream. REJUVEL 3D is a three-dimensional (3D) skin renewal system using National Aeronautics and Space Administration (NASA) technology. REJUVEL 3D has been formulated to address the skin care needs of both men and women of all skin types. The Company's subsidiaries include Rejuvel Int'l, Inc. and NueEarth, Inc.
Contact Information
- Headquarters
- 1173 Brook Drive EastDUNEDIN, FL, United States 34698
- Phone
- 786-787-0402
- Fax
- ---
Executives
- President, Treasurer, Secretary, Director
- Charles Scimeca
- Chief Executive Officer, Director
- Joseph Pavlik
- Chief Financial Officer, Director
- Matthew Cohen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.00 |
|---|---|
Revenue (TTM) | $187.3K |
Shares Outstanding | 51.8M |
Rejuvel Bio-Sciences Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.02 |
Book Value | $-0.02 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -672.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
